Abstract: A pressurized water nuclear reactor (PWNR) includes a core having a containment shield surrounding a reactor vessel having fuel assemblies that contain fuel rods filled with fuel pellets, and control rods, and a steam generator thermally coupled to the reactor vessel. A flow loop includes the steam generator, a turbine, and a condenser, and a pump for circulating a water-based heat transfer fluid in the loop. The heat transfer fluid includes a plurality of nanoparticles having at least one carbon allotrope or related carbon material dispersed therein, such as diamond nanoparticles.

Abstract: Carbon blacks, such as rubber blacks, having a low PAH concentration are described. Furthermore, elastomeric or rubber compositions containing the carbon black of the present invention are further described, as well as methods of making carbon black having a low PAH concentration.

Abstract: A carbon black having an I2 number from 30 mg/g to 200 mg/g and a DBP from 20 cc/100 g to 40 cc/100 g.

Abstract: An improved gas diffusion electrode composed of a perovskite-type oxide dispersed in a mixture of carbon black and a hydrophobic binder polymer. An improved catalyst for use in the electrochemical reduction of oxygen comprising a perovskite-type compound having alpha and beta sites, and having a greater molar ratio of cations at the beta site. A particularly good reduction catalyst is a neodymium calcium manganite. An improved method of dispersing the catalysts with carbon in a reaction layer of the electrode improves performance of the electrode and the oxygen reduction process. This is provided by adding carbon black to an aqueous solution of metal salts before it is heated to a gel and then to a char and then calcined. Optionally, a quantity of the desired oxide catalyst can be premixed with a portion the carbon before adding the carbon to an aqueous solution of the metal salts to be heated.

Abstract: Ultradispersed ones of primary particles of nanometer-sized carbon are obtained by applying a wet-type milling method and/or a wet dispersion method to an aggregate structure of the primary particles to overcome van der Waals forces, by which forces the primary particles are held together to form the aggregate structure, whereby the ultradispersed primary particles are obtained in a colloidal dispersion on a large-scale basis at low cost without using any additive. In a method of manufacturing the ultradispersed primary particles, the wet-type milling method is carried out in a ball mill, preferably in combination with a high-energy ultrasonic-wave process carried out in a dispersing medium such as pure water, whereby a colloidal solution or slurry with a low-concentration of the primary particles ultradispersed in the dispersing medium is obtained.

Abstract: Compositions and methods for administering a therapeutic agent to a mammal are disclosed. The compositions comprise either (i) vesicles comprising an amphiphilic substituted fullerene, wherein the therapeutic agent is present in the vesicle interior or between layers of the vesicle wall, (ii) a substituted fullerene, comprising a fullerene core and a functional moiety, wherein the therapeutic agent is associated with the substituted fullerene, or (iii) carbon nanotubes, wherein the therapeutic agent is covalently bonded to the carbon nanotubes.

Abstract: An contrast agent for therapeutic or diagnostic treatment comprises a fullerene scaffold and an iodinated moiety bonded to the scaffold. The agent may further comprise a water solubilizing moiety bonded to the scaffold, which may be a serinol malonodiamide, hydroxyl, and 1,3-diol. The fullerene scaffold may comprise an empty fullerene or an endohedral fullerene. A method for making the agent includes a) synthesizing iodinating moieties, b) protecting serinols, forming protected serinols, c) attaching the protected serinols to the iodinated moieties, forming iodinated serinols, d) attaching the iodinated serinols to the fullerene scaffold, and, optionally, d) de-protecting the serinols. Also disclosed are a method for providing diagnostic treatment to a patient comprising administering to said patient a radiopaque effective amount of a contrast agent comprising a fullerene scaffold and an iodinated moiety, a method of making a blood pool agent.